LEADER 00000cam 2200637Ii 4500 001 ocn904397961 003 OCoLC 005 20150929145334.0 006 m o d 007 cr cnu---unuuu 008 150305s2015 sz a ob 001 0 eng d 019 908098094 020 9783319111612|qelectronic bk. 020 3319111612|qelectronic bk. 024 7 10.1007/978-3-319-11161-2|2doi 035 (OCoLC)904397961|z(OCoLC)908098094 040 N$T|beng|erda|epn|cN$T|dN$T|dGW5XE|dE7B|dIDEBK|dUPM|dCOO |dYDXCP|dOCLCF|dOCLCO|dEBLCP|dOCLCO|dSTJ 049 STJJ 050 4 RC632.L5 072 7 HEA|x039000|2bisacsh 072 7 MED|x014000|2bisacsh 072 7 MED|x022000|2bisacsh 072 7 MED|x112000|2bisacsh 072 7 MED|x045000|2bisacsh 082 04 616.3997|223 099 PHARM WORLD WIDE WEB|aE-BOOK|aSPRINGER 245 00 Lipid management :|bfrom basics to clinic /|cHussein Yassine, editor. 264 1 Cham :|bSpringer,|c[2015] 264 4 |c©2015 300 1 online resource :|billustrations 336 text|btxt|2rdacontent 337 computer|bc|2rdamedia 338 online resource|bcr|2rdacarrier 504 Includes bibliographical references and index. 520 This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases. 588 0 Vendor-supplied metadata. 650 0 Lipids|xMetabolism. 650 0 Lipids|xMetabolism|xDisorders. 650 0 Hyperlipidemia. 650 0 Cholesterol|xMetabolism. 650 7 HEALTH & FITNESS / Diseases / General|2bisacsh 650 7 MEDICAL / Clinical Medicine|2bisacsh 650 7 MEDICAL / Diseases|2bisacsh 650 7 MEDICAL / Evidence-Based Medicine|2bisacsh 650 7 MEDICAL / Internal Medicine|2bisacsh 650 7 Cholesterol|xMetabolism.|2fast|0(OCoLC)fst00858430 650 7 Hyperlipidemia.|2fast|0(OCoLC)fst00965778 650 7 Lipids|xMetabolism.|2fast|0(OCoLC)fst00999374 650 7 Lipids|xMetabolism|xDisorders.|2fast|0(OCoLC)fst00999375 655 0 Electronic books. 700 1 Yassine, Hussein,|eeditor. 776 08 |iPrinted edition:|z9783319111605 994 01|bSTJ
|